Prostate Cancer

Oncology Solutions

The Patient Journey

One in seven men will be diagnosed with prostate cancer,¹ with 1.2 million new cases in 2018.² According to the American Cancer Society the overall 5-year survival rate is 99 percent for all stages of prostate cancer, however when diagnosed at stage IVB, the 5-year survival rate drops significantly to 29 percent.³

Diagnosis

SIGNA™ Architect AIR™ Edition

Our premium 3.0T, 70 cm wide bore MRI system leverages intelligent technology to enable patient-friendly exams with exceptional image quality.

LOGIQ General Imaging

Offering radiology, vascular, breast, interventional, MSK, cardiac, and OB/GYN applications, LOGIQ

PET/CT

The true potential of PET/CT is its ability to enable a true discovery.

pcc1
pcc2
PET/CT

Staging

Computed Tomography

Your need for quality patient care at low dose with greater productivity and affordability is more important than ever. That’s why we design CT syst...

SIGNA™ PETMR with QuantWorks

Our fully integrated PET/MR system combines TOF, quantitative accuracy and high sensitivity with our innovative Q.Clear reconstruction.

PET/CT

The true potential of PET/CT is its ability to enable a true discovery.

pcc1
pcc2
pcc3

Treatment Planning

Bone Health and Metabolic Health

Discovery RT

Discovery RT is a comprehensive radiation therapy solution that allows you to see all that your CT can see.

LOGIQ™ E10 Ultrasound Series

Next-generation, leadership ultrasound that adapts to your needs, today and into the future.

pcc1
pcc2
pcc3

Therapy and Monitoring

SIGNA™ PETMR with QuantWorks

Our fully integrated PET/MR system combines TOF, quantitative accuracy and high sensitivity with our innovative Q.Clear reconstruction.